| |
|
|
|
|
|
|
|||
|
PM Chen, SH Kwan, TS Hwang, BN Chiang and CK Chou
Tumor cells obtained from leukemia and lymphoma patients were investigated
for specific insulin receptors. Using radioactive 125I- labeled insulin,
specific insulin binding sites were demonstrated on most acute lymphocytic
leukemia (ALL) and acute myelocytic leukemia (AML) cells, including acute
promyelocytic leukemia (APL), chronic myelocytic leukemia (CML), and acute
monocytic leukemia (AMoL) cells. Insulin receptors were not found on
chronic lymphocytic leukemia (CLL) and malignant lymphoma (ML) cells.
Specific insulin binding sites were also found on monocytes and thymocytes
after treatment with phytohemagglutinin (PHA-P), but not on inactivated
tonsil cells, peripheral blood lymphocytes, or thymocytes. There was no
inverse correlation between the content of insulin receptors and the basal
level of circulating insulin. These data suggest that the insulin receptor
may be a new marker of acute leukemia and chronic myelocytic leukemia.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1983 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||